Katlama C - Search Results

1

Daily and on-demand HIV pre-exposure prophylaxis with emtricitabine and tenofovir disoproxil (ANRS PREVENIR): a prospective observational cohort study.

Molina JM, Ghosn J, Assoumou L, Delaugerre C, Algarte-Genin M, Pialoux G, Katlama C, Slama L, Liegeon G, Beniguel L, Ohayon M, Mouhim H, Goldwirt L, Spire B, Loze B, Surgers L, Pavie J, Lourenco J, Ben-Mechlia M, Le Mestre S, Rojas-Castro D, Costagliola D; ANRS PREVENIR Study Group. Molina JM, et al. Among authors: katlama c. Lancet HIV. 2022 Aug;9(8):e554-e562. doi: 10.1016/S2352-3018(22)00133-3. Epub 2022 Jun 27. Lancet HIV. 2022. PMID: 35772417

2

Potential efficacy of fumagillin in intestinal microsporidiosis due to Enterocytozoon bieneusi in patients with HIV infection: results of a drug screening study. The French Microsporidiosis Study Group.

Molina JM, Goguel J, Sarfati C, Chastang C, Desportes-Livage I, Michiels JF, Maslo C, Katlama C, Cotte L, Leport C, Raffi F, Derouin F, Modaï J. Molina JM, et al. Among authors: katlama c. AIDS. 1997 Nov;11(13):1603-10. doi: 10.1097/00002030-199713000-00009. AIDS. 1997. PMID: 9365765 Clinical Trial.

3

Efficacy and tolerability of stavudine plus lamivudine in treatment-naive and treatment-experienced patients with HIV-1 infection.

Katlama C, Valantin MA, Matheron S, Coutellier A, Calvez V, Descamps D, Longuet C, Bonmarchand M, Tubiana R, De Sa M, Lancar R, Agut H, Brun-Vezinet F, Costagliola D. Katlama C, et al. Ann Intern Med. 1998 Oct 1;129(7):525-31. doi: 10.7326/0003-4819-129-7-199810010-00003. Ann Intern Med. 1998. PMID: 9758571

4

[Polymorphism of protease genes in patients infected with HIV-1 and response to therapy including a protease inhibitor].

Mouroux M, Bossi P, Yvon-Groussin A, Delaugerre C, Valantin MA, Tubiana R, Coutellier A, Bonmarchand M, Bricaire F, Katlama C, Agut H, Huraux JM, Calvez V. Mouroux M, et al. Among authors: katlama c. Pathol Biol (Paris). 1999 May;47(5):549-52. Pathol Biol (Paris). 1999. PMID: 10418038 French.

5

Early virological failure in naive human immunodeficiency virus patients receiving saquinavir (soft gel capsule)-stavudine-zalcitabine (MIKADO trial) is not associated with mutations conferring viral resistance.

Mouroux M, Yvon-Groussin A, Peytavin G, Delaugerre C, Legrand M, Bossi P, Do B, Trylesinski A, Diquet B, Dohin E, Delfraissy JF, Katlama C, Calvez V. Mouroux M, et al. Among authors: katlama c. J Clin Microbiol. 2000 Jul;38(7):2726-30. doi: 10.1128/JCM.38.7.2726-2730.2000. J Clin Microbiol. 2000. PMID: 10878071 Free PMC article. Clinical Trial.

6

Transient mobilization of human immunodeficiency virus (HIV)-specific CD4 T-helper cells fails to control virus rebounds during intermittent antiretroviral therapy in chronic HIV type 1 infection.

Carcelain G, Tubiana R, Samri A, Calvez V, Delaugerre C, Agut H, Katlama C, Autran B. Carcelain G, et al. Among authors: katlama c. J Virol. 2001 Jan;75(1):234-41. doi: 10.1128/JVI.75.1.234-241.2001. J Virol. 2001. PMID: 11119593 Free PMC article.

7

Prevalence and conditions of selection of E44D/A and V118I human immunodeficiency virus type 1 reverse transcriptase mutations in clinical practice.

Delaugerre C, Mouroux M, Yvon-Groussin A, Simon A, Angleraud F, Huraux JM, Agut H, Katlama C, Calvez V. Delaugerre C, et al. Among authors: katlama c. Antimicrob Agents Chemother. 2001 Mar;45(3):946-8. doi: 10.1128/AAC.45.3.946-948.2001. Antimicrob Agents Chemother. 2001. PMID: 11181387 Free PMC article.

8

Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy.

Besson C, Goubar A, Gabarre J, Rozenbaum W, Pialoux G, Châtelet FP, Katlama C, Charlotte F, Dupont B, Brousse N, Huerre M, Mikol J, Camparo P, Mokhtari K, Tulliez M, Salmon-Céron D, Boué F, Costagliola D, Raphaël M. Besson C, et al. Among authors: katlama c. Blood. 2001 Oct 15;98(8):2339-44. doi: 10.1182/blood.v98.8.2339. Blood. 2001. PMID: 11588028 Free article.

9

Resistance profile and cross-resistance of HIV-1 among patients failing a non-nucleoside reverse transcriptase inhibitor-containing regimen.

Delaugerre C, Rohban R, Simon A, Mouroux M, Tricot C, Agher R, Huraux JM, Katlama C, Calvez V. Delaugerre C, et al. Among authors: katlama c. J Med Virol. 2001 Nov;65(3):445-8. J Med Virol. 2001. PMID: 11596076

10

Re-occurrence of HIV-1 drug mutations after treatment re-initiation following interruption in patients with multiple treatment failure.

Delaugerre C, Valantin MA, Mouroux M, Bonmarchand M, Carcelain G, Duvivier C, Tubiana R, Simon A, Bricaire F, Agut H, Autran B, Katlama C, Calvez V. Delaugerre C, et al. Among authors: katlama c. AIDS. 2001 Nov 9;15(16):2189-91. doi: 10.1097/00002030-200111090-00016. AIDS. 2001. PMID: 11684940 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

932 results

Search Page